Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

towfiqu-barbhuiya-hn2hqoalbck-unsplash_1

National Institutes of Health awards grant for gammaCore clinical trial for patients with opioid use disorders

April 27, 2023 Research and Development

Bioelectronic medicine and wellness company electroCore have announced that the National Institute on Drug Abuse (NIDA) part of the National …
News
testalize-me-0je8ynv4mis-unsplash

3B Pharmaceuticals and Novartis enter into licensing agreement for FAP-targeting technology

April 25, 2023 Research and Development

German biotechnology company 3B Pharmaceuticals (3BP) and Switzerland-based Novartis have announced that they have entered into a Global Exclusive Licensing …
News
towfiqu-barbhuiya-hn2hqoalbck-unsplash_1

AbbVie shares results from phase 3 trial for atogepant migraine treatment

April 24, 2023 Research and Development

AbbVie has shared positive results from its phase 3 ELEVATE study, which assessed atogepant for the preventative treatment of episodic …
News
yunus-tug-lnfgdbcajxu-unsplash

Gamida Cell’s Omisirge receives FDA approval

April 18, 2023 Research and Development

Cell therapy pioneer Gamida Cell has announced FDA approval of its allogeneic cell therapy, Omisirge (omidubicel-onlv), for use in adult …
News
towfiqu-barbhuiya-ssz6x-gao0c-unsplash

GSK announces positive data from phase 3 trial for new UTI antibiotic

April 17, 2023 Research and Development

GSK has shared positive data from its phase 3 trial for gepotidacin as a new oral antibiotic for the treatment …
News
towfiqu-barbhuiya-msqb97guxy0-unsplash

Diabeloop announces collaboration with Novo Nordisk for connected diabetes treatment

April 14, 2023 Research and Development

Automated insulin delivery company Diabeloop has announced its collaboration with global healthcare company Novo Nordisk, with an agreement which covers …
News
steven-hwg-zbsdrthiim4-unsplash

Merck’s relapsing multiple sclerosis trial put on FDA partial clinical hold over liver injuries

April 14, 2023 Research and Development

Merck has announced that its clinical phase 3 study EVOLUTION has been put on partial clinical hold by the FDA …
News
robina-weermeijer-3kgf9r_0ohs-unsplash_2

Biogen announces licensing of Denali’s ATV to target Amyloid Beta

April 13, 2023 Research and Development

Biogen and Denali Therapeutics have announced that Biogen has exercised its option to license Denali’s Antibody Transport Vehicle: Amyloid beta …
News
minku-kang-acnintiifd8-unsplash_1

Aspect Biosystems and Novo Nordisk partner with $75m deal to develop bioprinted tissue therapeutics

April 13, 2023 Research and Development

Canadian biotech company Aspect Biosystems and Denmark-based Novo Nordisk have announced a collaboration, development and license agreement to develop bioprinted …
News
diana-polekhina-zbsthwt9vlc-unsplash_2

Moderna announces mixed success clinical updates for mRNA pipeline

April 12, 2023 Research and Development

Biotechnology company Moderna has announced clinical updates detailing the expansion and advancement of its mRNA pipeline, which includes treatments for …
News
christina-victoria-craft-zhys6xn7sue-unsplash_5

Molecular Templates announces hold for phase 1 study

April 11, 2023 Research and Development

Molecular Templates has announced that the FDA has placed a partial hold on its phase 1 study for MT-0169 based …
News
chuttersnap-oijvdm3zx4i-unsplash

Synapse receives FDA approval for its NeuRx DPS to treat patients with stable SCI

April 6, 2023 Research and Development

Synapse Biomedical has announced that it has gained premarket approval (PMA) from the FDA for its NeuRxDiaphragm Pacing System (NeuRx …
News
brano-mm1vipqd0oa-unsplash

Vertex Pharmaceuticals and CRISPR Therapeutics submit FDA rolling Biologics License Applications for gene editing-based medicine

April 4, 2023 Research and Development

US-based Vertex Pharmaceuticals and Swiss CRISPR Therapeutics have announced the completion of their rolling Biologics License Applications (BLAs) to the …
News
ed-us-k0dml4nmopo-unsplash

aVaxziPen announces positive data for multiple diseases with novel needle-free vaccine

April 3, 2023 Research and Development

aVaxziPen, a biotech company focusing on the development of a novel needle-free vaccine delivery platform, has announced that it will …
News

Janssen reports new Rybrevant data for patients with advanced non-small cell lung cancer

March 30, 2023 Research and Development

Janssen, part of Johnson & Johnson, has announce new long-term data from its CHRYSALIS study, which assessed Rybrevant (amivantamab) in …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025